Login

Healthcare

00:10:00
CEO Ben Lightburn Discusses Advancing Psychedelic Medicine through Natural Extraction | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Pioneering Drug Development for Inflammation and Cancer | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Filament Health and Reset Pharmaceuticals Strike Licensing Deal for Psilocybin Drug PEX010 | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Filament Health Partners with Entheotech in Exclusive Licensing and Co-Development Agreement | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
CEO Thomas Olin on Innovation and Biopharma Advances | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Philogen CEO Dario Neri Introduces the Company to the City | Dario Neri, CEO ,Philogen spa.
00:10:00
Kancera CEO Thomas Olin Discusses Kand567 Phase 2 Studies for COVID-19 and Acute Myocardial Infarction | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pioneering Safe and Accessible Natural Psychedelics for Healing | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Ben Lightburn Discusses Filament Health's Mission to Standardize Natural Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
CEO Spotlight: Benjamin Lightburn on Filament Health's Mission and Milestones | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Jeong-gyu Lee Shares Insights on Drug Development and Startup Success | James Lee, CEO , Bridge Biotherapeutics Inc.

© 2026 Nehu